2026
2026 funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
PRRI Public Fellows 2026-2027 (Historical Reference)
Historical reference for PRRI's closed 2026-2027 Public Fellows cohort: an 11-month, non-residential fellowship for nine scholars working at the intersection of religion, culture, politics, and PRRI's research areas, with a USD 5,000 annual stipend and additional collaborative research support.
Public Engagement Spark Awards 2026A
UK public engagement projects linked to STFC remit can receive up to £20,000 (100% FEC) through the UKRI STFC Public Engagement Spark Awards 2026A, with applications due 25 August 2026.
Public Sector Loan Facility 2026-2027 (JTM-2026-PSLF): EU support for climate transition projects
The European Climate, Infrastructure and Environment Executive Agency is running the second Public Sector Loan Facility (PSLF) call for 2026-2027, with a total grant budget of €630 million and two application tracks for EU member-state entities.
Queen Elizabeth Prize for Engineering 2027 Nominations (Global £500,000 Prize)
Historical reference for the closed 2027 QEPrize nomination cycle: a global £500,000 engineering prize whose nominations closed on 26 June 2026. The official site has not announced the next cycle.
RFA-CA-27-006: NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
A federal clinical-research cooperative agreement for US institutions to serve as NCORP research hubs that run cancer prevention, treatment, symptom-management, and care-delivery trials in community settings.
RFA-CA-27-021: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
The National Cancer Institute's RFA-CA-27-021 supports continued operations and improvement of existing, widely adopted informatics tools and resources for cancer research, with awards capped at $600,000 in direct costs per year for up to five years.
RFA-DA-26-034: Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on the Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic Opioids
NIH Trans-NIH RFA supports basic and applied research on acute exposure effects and delayed effects of ultra-potent synthetic opioids, with recurring R01 due dates in 2026 and 2027.
RFA-HD-27-012: Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)
A limited-competition NIH renewal for existing NICHD IDDRCs, this NOFO funds interdisciplinary P50 centers advancing translational, biomarker, and real-world research for intellectual and developmental disabilities.
RFA-HL-26-019: Catalyze Product Definition - Medical Device Prototype Design/Testing and Disease Target Identification and Assay Development (R61/R33; Clinical Trial Not Allowed)
NIH NHLBI Catalyze Product Definition NOFO for early-stage device, diagnostic, and research-tool development in heart, lung, blood, and sleep diseases. The next new-application due date is October 21, 2026.
RFA-HL-27-004: Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
NIH’s NHLBI RFA-HL-27-004 is a limited-competition R03 small grant opportunity to help current and recently completed NHLBI K01/K08/K23/K25 awardees advance toward independent funding through a short, NIH-funded pilot- to proof-of-concept scale project.